Stay updated on Risankizumab in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.

Latest updates to the Risankizumab in Ulcerative Colitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the Record History page for NCT03398148.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.3 was added and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, these are administrative footer updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe Record History now includes an added revision entry for v3.3.2 and removes the v3.2.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page no longer displays the government funding and NIH operating status notice. This change does not affect the clinical trial data or submission process.SummaryDifference0.2%

- Check81 days agoChange DetectedVersion history shows minor metadata updates and intermittent IPDSharing tagging; core study information such as design and outcomes remains unchanged.SummaryDifference0.0%

- Check110 days agoChange Detected- Added a prominent operations/status notice and updated to v3.2.0. - Removed reference to v3.1.0.SummaryDifference6%

Stay in the know with updates to Risankizumab in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.